N-acetyltransferase 2 slow genotype together with tobacco smoking increases bladder cancer risk. Patients with N-acetyltransferase 2 slow genotypes were more likely to develop a high-grade and invasive tumor. N-acetyltransferase 2 slow genotype is an important genetic determinant for bladder cancer in Bangladesh population.
TP53 is considered to be the most frequently mutated gene in every forms of human cancer. The objective of this study was to evaluate the association of TP53 codon 72 and 248 polymorphisms with the susceptibility and severity of bladder cancer in Bangladeshi population. A case-control study on 102 bladder cancer patients and 140 control subjects was conducted. The genotype analysis was done by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) method. The patients with Pro/Pro genotypes at 72 position were at high risk (odds ratio (OR) = 3.02; 95 % confidence interval (95 % CI) = 1.42 to 6.40) of developing bladder cancer. The cigarette smokers with Pro/Pro genotypes at 72 position were found to have a 3.91-fold increased risk to develop bladder cancer (OR = 3.91; 95 % CI = 1.33 to 11.5). There was no significant association of codon 248 polymorphisms with bladder cancer in the study population. Taken together, these findings indicate an association between p53 codon72 polymorphism and bladder cancer risk in Bangladeshi population.
Worldwide, pre‐eclampsia (PE) ranks as a major obstetric problem leading to substantial maternal and perinatal morbidity and mortality, especially in developing countries. Clinically it appears as a maternal syndrome, including hypertension and proteinuria after second half of pregnancy. PE affected by genetic trait, is associated with oxidative stress due to imbalance between the production of reactive oxygen species and the ability of antioxidant process. The glutathione S‐transferases (GST) are a group of enzymes which are involved in protecting cells from oxidative stress. In our study, we evaluated the risk of developing preeclampsia related to GSTT1 and GSTM1 genotypes. 104 patients having preeclampsia and 200 healthy controls having no history of preeclampsia were recruited for the study after getting written consent from them. DNA was extracted from the blood and Polymerase Chain Reaction (PCR) method was used to identify genotypes of GSTT1 and GSTM1 in study subjects. We used odds ratio to calculate the risk between cases and controls using SPSS 17. Genotype frequency of GSTM1 nul genotype showed significant difference between case and control group (p<0.001). Combined null genotype for GSTT1 and GSTM1 showed significant difference between two groups when compared to combined present genotype for GSTT1 and GSTM1 (p<0.001). There was significant association for GSTM1 null genotype with the development of preeclampsia (p<0.001) and the odds ratio was significantly higher in patients compared to control subjects (OR=4.75; 95% CI=2.17–10.39). For GSTT null genotype, there was increased risk for developing preeclampsia but the association was not significant (OR=1.22; 95% CI=0.58–2.57).In case of GSTT1 and GSTM1 combined genotype, patients having both null genotypes for GSTT1 and GSTM1 showed significance (p<0.001) and higher risk of developing preeclampsia when compared to control subjects (OR=7.64; 95% CI=2.38–24.60). We found a significant association between GSTM1 null genotype and the risk of developing preeclampsia in Bangladeshi population. No risk was found for GSTT1 null genotype and preeclampsia. For combined null genotype of GSTT1 and GSTM1, the risk was even higher relative to the risk of either GSTT1 null or GSTM1 null genotype alone.Support or Funding InformationDear colleague, I hereby, would like to express my motivation with this letter to attend the American Society for Biochemistry and Molecular Biology at San Diego, USA from 21–25 April 2018.The conference topics are relevant to my professional skills, and therefore I would welcome the opportunity to attend this conference having researchers from different countries of the world. I am working as an program coordinator at RHSTEP and at the same working as a predatory PhD student at Department of Biochemistry and Molecular Biology of Dhaka University.As a unique added value of this event, I will find a chance for networking with other scientists from different countries, which is an excellent opportunity for horizontal exchange of knowledge and experience. This networking will expand my opportunities for planning collaborative research projects in future.I have completed my MBBS from Moulana Bhasani Medical College and MPH from American International University, Bangladesh. In case of all three degrees, the medium of instruction was English.Unfortunately I do not have fund to attend this conference and I will apply for a travel grant.My attendance at this training will be very helpful for my carrier development and I would highly appreciate to be one of the selected participants.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.